Nanobiotix Aktie - NANO

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

3,87

Gebot

3,812

Fragen

4,00

Volumen

743.439

3,546 Tagesbereich 4,298

2,668 52-Wochen-Bereich 7,02

Marktkapitalisierung

134,776M

Handelsende

3,45

Handelsbeginn

3,556

Letzte Trade

222

3.87

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

94.396

Ausgegebene Aktien

34.825.872

Dividendenrendite

Kurs-Gewinn-Verhältnis

-3,39

Gewinn pro Aktie (EPS)

-1,14

Erlöse

36,21M

Nettogewinn

-39,7M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.nanobiotix.com

Hauptsitz

Paris, Paris, Fra

Gegründet

Nanobiotix is listed in the Pharmaceutical Preparations sector of the Euronext with ticker NANO. The last closing price for Nanobiotix was 3,45 €. Over the last year, Nanobiotix shares have traded in a share price range of 2,668 € to 7,02 €.

Nanobiotix currently has 34.825.872 shares in issue. The market capitalisation of Nanobiotix is 120,15 € million. Nanobiotix has a price to earnings ratio (PE ratio) of -3.39.

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Généralde...

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority...

Voting Rights and Shares Capital of the Company

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Jan...

NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022

Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities...

DE NOUVELLES DONNÉES SUR NBTXR3, PRODUIT CANDIDAT PRINCIPAL DE NANOBIOTIX, SERONT PRÉSENTÉES LORS DE LA RÉUNION ANNUELLE DE L'ASCO 2022

Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - la « Société ») est une société française de biotechnologie en phase de développement clinique avancé, pionnière des approches...

NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3

Data presented at the 2022 Annual Meeting of the American Association of Cancer Research New data from an open-label preclinical study in mice evaluating the changes in immune-related genes...

NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.422	12.2389791183	3.448	4.298	3.282	70907	3.4157408	DE
4	0.92	31.186440678	2.95	4.298	2.83	70045	3.24459508	DE
12	-0.028	-0.718317085685	3.898	4.298	2.668	94396	3.16734582	DE
26	-0.62	-13.8084632517	4.49	5.3	2.668	71316	3.70261672	DE
52	-3.09	-44.3965517241	6.96	7.02	2.668	68748	4.50095319	DE
156	-3.595	-48.158070998	7.465	10.4	1.612	118627	5.58967217	DE
260	-4.14	-51.6853932584	8.01	17.26	1.612	116511	7.04656539	DE

NANO - Frequently Asked Questions (FAQ)

What is the current Nanobiotix share price?

The current share price of Nanobiotix is 3,87 €

How many Nanobiotix shares are in issue?

Nanobiotix has 34.825.872 shares in issue

What is the market cap of Nanobiotix?

The market capitalisation of Nanobiotix is EUR 120,15M

What is the 1 year trading range for Nanobiotix share price?

Nanobiotix has traded in the range of 2,668 € to 7,02 € during the past year

What is the PE ratio of Nanobiotix?

The price to earnings ratio of Nanobiotix is -3,39

What is the cash to sales ratio of Nanobiotix?

The cash to sales ratio of Nanobiotix is 3,72

What is the reporting currency for Nanobiotix?

Nanobiotix reports financial results in EUR

What is the latest annual turnover for Nanobiotix?

The latest annual turnover of Nanobiotix is EUR 36,21M

What is the latest annual profit for Nanobiotix?

The latest annual profit of Nanobiotix is EUR -39,7M

What is the registered address of Nanobiotix?

The registered address for Nanobiotix is 60 RUE DE WATTIGNIES, PARIS, PARIS, 75012

What is the Nanobiotix website address?

The website address for Nanobiotix is www.nanobiotix.com

Which industry sector does Nanobiotix operate in?

Nanobiotix operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ALCABCabasse SA	0,77 € (67,39%)	27,75k
ALEXPOne Experience	0,496 € (64,24%)	2,54k
VTRVitura	5,80 € (62,92%)	2,37k
DMSBSDiagnostic Medical Systems	0,007 € (40,00%)	15,1k
ALVERVergnet	0,0009 € (28,57%)	23,09M
ALCYBCybergun	0,0001 € (-50,00%)	18,59M
BAIOdyssey Acquisition SA	0,1285 € (-49,80%)	834,05k
ALALOAcheterLouerFR	0,0148 € (-34,80%)	2,31M
MLWEYWeya	0,018 € (-33,33%)	52,31k
MLCOTCoretech 5	0,0335 € (-33,00%)	61k
ATOAtos SE	0,0021 € (0,00%)	90,2M
ALVERVergnet	0,0009 € (28,57%)	23,09M
BCPBanco Comercial Portugues SA	0,5008 € (-1,14%)	10,34M
ALNRGEnergisme SA	0,0039 € (5,41%)	10,05M
ALHGLouis Hachette Group	1,331 € (-2,90%)	8,08M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Nanobiotix (NANO)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Nanobiotix

NANO Neueste Nachrichten

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company

NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022

DE NOUVELLES DONNÉES SUR NBTXR3, PRODUIT CANDIDAT PRINCIPAL DE NANOBIOTIX, SERONT PRÉSENTÉES LORS DE LA RÉUNION ANNUELLE DE L'ASCO 2022

NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3

NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F

Voting Rights and Shares Capital of the Company

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Voting Rights and Shares Capital of the Company

NANO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Nanobiotix (NANO) Börsenkurse

Nanobiotix (NANO)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Nanobiotix

NANO Neueste Nachrichten

NANO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen